Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer

Curr Drug Targets. 2020;21(14):1397-1404. doi: 10.2174/1389450120666191112141901.

Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide. In developed countries, its mortality remains high, yet the prevalence has established owing to effective screening programs; however due to the westernization of lifestyle, the incidences in many other countries have increased. Although the treatment of CRC has improved in the last few years, the side effects of these approaches cannot be neglected. Recently, members of the family of free fatty acid receptors (FFARs) have become attractive pharmacological targets in many diseases, including asthma; studies also point to their role in carcinogenesis. Here, we discuss current knowledge and future directions in FFAR research related to CRC. Contradictory results of FFARs modulation may derive from the pleiotropic effects of FFAR ligands, receptor distribution and different signal transduction. Hence, we indicate directions of further studies to fully use the potential of FFARs in CRC.

Keywords: Free fatty acids receptors; G protein-coupled receptors; cancer; colorectal cancer; diet; fatty acids.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Colorectal Neoplasms / diet therapy
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / metabolism*
  • Diet
  • Fatty Acids, Nonesterified / metabolism*
  • Gastrointestinal Microbiome
  • Humans
  • Ligands
  • Receptors, G-Protein-Coupled / agonists
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism*

Substances

  • Fatty Acids, Nonesterified
  • Ligands
  • Receptors, G-Protein-Coupled